@CpaTennessee @MethodistHlth @MayorMemphis @memphisnews Dr Mazumder is part of the COVID-19 Study Team. The team of 36 co-authored these 2 peer-reviewed articles, along with more than 20 experts. Please let us know how your clinical experience contradic…
SARS CoV-2 infection among patients using immunomodulatory therapies https://t.co/4rQADIctOk
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
#JustPublished in @ARD_BMJ: What is the risk of #COVID19 and disease progression among patients using immunomodulatory therapy? Read the study: https://t.co/VN4YLPq5QV https://t.co/3tzFh9uUoZ
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
@decompress
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
RT @philipcrobinson: A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infecti…
A report of 77 cases of SARS CoV-2 infection among patients using immunomodulatory therapies from the Emerging Infections Network, again makes anti-TNF look pretty good, no deaths or ventilation for those on anti-TNF. Published in @ARD_BMJ https://t.co/…